Signet Financial Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.35M Sell
13,724
-730
-5% -$170K 0.38% 88
2025
Q4
$2.99M Sell
14,454
-1,395
-9% -$276K 0.33% 98
2025
Q3
$2.94M Sell
15,849
-500
-3% -$85.7K 0.34% 95
2025
Q2
$2.5M Sell
16,349
-968
-6% -$149K 0.31% 100
2025
Q1
$2.87M Sell
17,317
-623
-3% -$97.5K 0.39% 86
2024
Q4
$2.59M Buy
17,940
+1,775
+11% +$275K 0.33% 94
2024
Q3
$2.62M Sell
16,165
-448
-3% -$71.4K 0.33% 95
2024
Q2
$2.43M Buy
16,613
+639
+4% +$95K 0.33% 97
2024
Q1
$2.53M Buy
15,974
+268
+2% +$42.7K 0.35% 93
2023
Q4
$2.46M Sell
15,706
-187
-1% -$28.7K 0.37% 85
2023
Q3
$2.48M Sell
15,893
-582
-4% -$96K 0.41% 83
2023
Q2
$2.73M Sell
16,475
-210
-1% -$33.9K 0.43% 77
2023
Q1
$2.59M Sell
16,685
-242
-1% -$39.1K 0.44% 76
2022
Q4
$2.99M Buy
16,927
+481
+3% +$83.1K 0.53% 57
2022
Q3
$2.69M Buy
16,446
+65
+0.4% +$11K 0.53% 55
2022
Q2
$2.91M Sell
16,381
-44
-0.3% -$7.84K 0.55% 52
2022
Q1
$2.91M Buy
16,425
+979
+6% +$167K 0.49% 59
2021
Q4
$2.64M Sell
15,446
-941
-6% -$154K 0.4% 65
2021
Q3
$2.65M Buy
+16,387
New +$2.8M 0.46% 61
2021
Q2
Sell
-15,782
Closed -$2.59M 180
2021
Q1
$2.59M Buy
15,782
+384
+2% +$62.1K 0.49% 61
2020
Q4
$2.42M Buy
15,398
+287
+2% +$42.4K 0.49% 61
2020
Q3
$2.11M Sell
15,111
-601
-4% -$88.9K 0.47% 67
2020
Q2
$2.33M Sell
15,712
-10,512
-40% -$1.53M 0.52% 61
2020
Q1
$3.86M Buy
26,224
+93
+0.4% +$13.2K 0.91% 28
2019
Q4
$3.81M Buy
26,131
+602
+2% +$81.7K 0.71% 49
2019
Q3
$3.37M Buy
25,529
+289
+1% +$38.1K 0.66% 54
2019
Q2
$3.3M Sell
25,240
-1
-0% -$138 0.65% 58
2019
Q1
$3.57M Sell
25,241
-312
-1% -$41.8K 0.7% 58
2018
Q4
$3.3M Buy
25,553
+848
+3% +$118K 0.72% 52
2018
Q3
$3.41M Sell
24,705
-25
-0.1% -$3.32K 0.6% 59
2018
Q2
$3M Sell
24,730
-49
-0.2% -$6.11K 0.53% 69
2018
Q1
$3.17M Sell
24,779
-252
-1% -$34.1K 0.57% 64
2017
Q4
$3.5M Sell
25,031
-888
-3% -$124K 0.65% 58
2017
Q3
$3.37M Sell
25,919
-291
-1% -$38.6K 0.66% 63
2017
Q2
$3.47M Sell
26,210
-437
-2% -$55.7K 0.73% 55
2017
Q1
$3.32M Buy
26,647
+11,468
+76% +$1.37M 0.72% 55
2016
Q4
$1.75M Sell
15,179
-1,287
-8% -$149K 0.42% 68
2016
Q3
$1.95M Buy
16,466
+2,896
+21% +$351K 0.46% 63
2016
Q2
$1.65M Sell
13,570
-3,407
-20% -$387K 0.38% 66
2016
Q1
$1.84M Buy
16,977
+2,039
+14% +$211K 0.39% 64
2015
Q4
$1.53M Buy
14,938
+2,636
+21% +$265K 0.31% 69
2015
Q3
$1.15M Buy
12,302
+6,045
+97% +$585K 0.26% 72
2015
Q2
$610K Sell
6,257
-4,071
-39% -$408K 0.14% 95
2015
Q1
$1.04M Buy
+10,328
New +$1.05M 0.29% 76

Other funds holding JNJ

Signet Financial Management's JNJ Position: Q1 2026 in Review

Signet Financial Management reduced its Johnson & Johnson (JNJ) stake by 5.1% in Q1 2026, selling an estimated $170K and leaving 13,724 shares worth $3.35M. The position accounts for 0.38% of the portfolio, ranked #88.

Signet Financial Management first reported a position in JNJ in Q1 2015 and has held it in 44 quarters since. The position peaked at $3.86M in Q1 2020. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Signet Financial Management held 13,724 shares of Johnson & Johnson worth $3.35M as of Q1 2026.
  • Signet Financial Management sold 730 Johnson & Johnson shares in Q1 2026, an estimated $170K.
  • Johnson & Johnson made up 0.38% of Signet Financial Management's portfolio in Q1 2026, its #88 holding.
  • Signet Financial Management first reported a position in Johnson & Johnson in Q1 2015 and has held it in 44 quarters since.
  • Signet Financial Management's Johnson & Johnson position peaked at $3.86M in Q1 2020.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.